- 항암 화학요법을 받는 환자들에서의 중심정맥삽관술
- ㆍ 저자명
- 김욱성,김기봉,Kim. Uk-Seong,Kim. Gi-Bong
- ㆍ 간행물명
- 大韓胸部外科學會誌
- ㆍ 권/호정보
- 1993년|26권 6호|pp.483-487 (5 pages)
- ㆍ 발행정보
- 대한흉부외과학회
- ㆍ 파일정보
- 정기간행물| PDF텍스트
- ㆍ 주제분야
- 기타
From July 1990 to August 1992,78 Hickman catheters and 22 chemoports were inserted in 98 patients for chemotherapy.We analyzed the clinical data of these patients. The results were as follows: 1]Mean age of patients was 42.8$pm$1.6[SE] years 2]Male to female ratio was 1.09:1 3]The diseases of the cases were leukemia[66] ,lymphoma[8], stomach cancer[8],uterine cervix cancer[5],ovarian cancer[4],lung cancer[3],aplastic anemia[2],maxillary gland cancer[1],pancreas cancer[1],malignant mesothelioma[1] and multiple myeloma[1] 4]Mean values of preoperative WBC counts,platelet counts,PT and APTT were 31,500$pm$ 8,132[SE]/mm,104,000$pm$ 12,200 [SE]/mm,82$pm$ 1.9[SE]% and 32$pm$ 0.8[SE] sec,respectively. 5]The average duration of catheter uses was 121.7$pm$ 17.3[SE]days. 6]The complications were subcutaneous tunnel bleeding or hematoma[2],exit site or subcutaneous tunnel infection[2] and catheter related septicemia[1]. 7]The causes of catheter removal were patient`s death or hopeless discharge[22],completion of treatment[6],subcutaneus hematoma or bleeding[2],exit site or subcutaneous tunnel infection[2] and catheter related septicemia[1].So,we concluded that Hickman catheter and chemoport were useful vascular access for chemotherapy in patients with malignant diseases, with low rate of complication and longterm duration.